Search for: "Astra Zeneca" Results 41 - 60 of 63
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Nov 2012, 7:50 am
* On Thursday 6 December, judgment will be given in Case C‑457/10 P AstraZeneca AB and Astra Zeneca plc v European Commission. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
1 Oct 2009, 4:47 am
A number of plaintiffs have filed individual lawsuits against pain pump (I-Flow, Don Joy, Stryker, Moog, Breg, and others) and anesthetic drug manufacturers (Astra-Zeneca, Abbott, and others) after suffering catastrophic cartilage damage as a result of intra-articular injection of pain medications. [read post]
8 Oct 2020, 7:26 am by Michael Geist
Years of publicly funded research has been essential in supporting the race to find an effective COVID-19 vaccine, serving as the foundation for the Astra-Zeneca/Oxford vaccine candidate. [read post]
23 Oct 2008, 10:18 am
Kelly's departure appears to have been closely linked to Vice Chairman Karen Katen's decision to "reflect on both her professional and ...peterrost.blogspot.com/2007/01/pfizer-ceo-eliminates-karen-katen.html - 68k - Cached - Similar pages - Note thisMore results from peterrost.blogspot.com »And even if you want to find out about an old pharma CEO, like Astra-Zeneca's Lars Bildman, Google will give you the Peter Rost blog ranked #3:THE PETER ROST… [read post]
3 Jun 2020, 1:06 am by Roya Ghafele (OxFirst)
In the UK the government bets on a collaboration between Oxford University and the British Pharmaceutical Company Astra Zeneca. [read post]
12 Jun 2008, 10:40 pm
Indeed, many of the large life sciences companies that have been targeted in securities suits in recent months – including, for example, Guidant, Pfizer and Astra Zeneca – have successfully managed to get the cases dismissed. [read post]
17 Feb 2010, 5:10 am
King Pharmaceuticals Inc. et al (Patent Docs) Famvir (Famciclovir) – US: Teva and Novartis settle patent litigation regarding Famciclovir (IP Factor) (SmartBrief) Gardasil, Silgard - Portugal: More on Gardasil and Silgard from Portugal (SPC Blog) Lipitor (Atorvastatin) – Philippines: UniLab can still sell generic version of Pfizer's Lipitor after a Makati court denies latter's petition for preliminary injunction (GenericsWeb) Mucinex (Guaifenesin) – US: W D Michigan rules… [read post]
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
As the BBC commented in an analysis: “Unlike rivals Astra Zeneca and Johnson & Johnson which vowed to forego profits on the vaccine during the pandemic, Pfizer planned to make money on its vaccines. [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
As the BBC commented in an analysis: “Unlike rivals Astra Zeneca and Johnson & Johnson which vowed to forego profits on the vaccine during the pandemic, Pfizer planned to make money on its vaccines. [read post]
14 Apr 2021, 6:49 am by Matthieu Dhenne (Ipsilon)
Similarly, Oxford University holds patents on the recombinant DNA technology used in Astra Zeneca’s vaccine, to which Oxford University has granted an exclusive license[4]. [read post]
6 Apr 2022, 6:35 am by The Petrie-Flom Center Staff
For example, although Astra Zeneca did not aim to maximize profits at the beginning of the pandemic, it declared low-cost pricing for its COVID-19 vaccine to be over before the Omicron wave started. [read post]
27 Jan 2021, 1:44 pm by Kevin LaCroix
  The complaint alleges that the company’s various communications leading up to the news of the mixed clinical trial results on November 23 were false and/or misleading because the communications failed to disclose that:   (a) that initial clinical trials for AZD1222 had suffered from a critical manufacturing error, resulting in a substantial number of trial participants receiving half the designated dosage; (b) that clinical trials for AZD1222 consisted of a patchwork of disparate… [read post]
17 Jul 2012, 6:10 am by Ruth Bonino
 The High Court also said he was in breach of contractual and fiduciary duties in canvassing Mr Boardman of Astra Zeneca and not informing CS of what he was doing. [read post]
15 Aug 2021, 11:51 pm by Radhi Shah (USC Gould School of Law)
AstraZeneca   The following case illustrates license sought for Saxagliptin® which is used in the treatment of Type-II Diabetes Mellitus On June 29, 2015, Lee Pharma filed an application for compulsory license for patent covering Astra Zeneca’s diabetes management drug Saxagliptin®. [read post]